Clinical Trial Update: A Study of the Efficacy and Safety of the LEISH-F2 + MPL-SE Vaccine for Treatment of Cutaneous Leishmaniasis [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the LEISH-F2 vaccine with MPL-SE adjuvant for treating cutaneous leishmaniasis has completed, with results posted in 2013. The update s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Leishmaniasis

Drugs mentioned

• LEISH-F2 + MPL-SE vaccine (LEISH-F2 vaccine with MPL-SE adjuvant)

Snippet

Sponsor: Access to Advanced Health Institute (AAHI) | Conditions: Cutaneous Leishmaniasis | Phase 2 | Status: COMPLETED | Results posted: 2013-11-18